Tag: VARISURE

J&J presents early outcomes from OMNY-AF pilot study alongside new Varipulse...

Johnson & Johnson (J&J) has announced 12-month pilot-phase data from the OMNY-AF study evaluating its investigational Omnypulse platform for the treatment of symptomatic paroxysmal...